echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: The main etiology of cerebral hemorrhage in the elderly: longitudinal development of hereditary CAA magnetic resonance markers and cognitive ability

    Stroke: The main etiology of cerebral hemorrhage in the elderly: longitudinal development of hereditary CAA magnetic resonance markers and cognitive ability

    • Last Update: 2022-04-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cerebrovascular amyloid disease (CAA) is one of the main causes of spontaneous cerebral hemorrhage in the elderly .
    Most patients are admitted to hospital due to cerebral hemorrhage, and the recurrence rate of CAA-related cerebral hemorrhage is high.
    Patient prognosis is particularly important
    .

    Cerebrovascular amyloid disease (CAA) is one of the leading causes of spontaneous cerebral hemorrhage in the elderly

    The main imaging manifestations of CAA include lobar hemorrhage, cerebral microhemorrhage, cerebral convex subarachnoid hemorrhage, and cerebral surface iron deposition.
    The susceptibility-weighted imaging sequence can be routinely used in clinic to increase the detection rate of CAA lesions
    .
    Among them, β-amyloid (Aβ) deposition in the cortex and leptomeningeal vessels is the main pathological feature of CAA


    .


    Among them, β-amyloid (Aβ) deposition in the cortex and leptomeningeal vessels is the main pathological feature of CAA


    To this end, scholars from Leiden University in the Netherlands took advantage of the unique opportunity provided by the study of Dutch-type hereditary cerebral amyloid angiopathy (D-CAA) to determine the longitudinal development of CAA biomarkers in the presymptomatic and symptomatic phases of the disease.
    Results Published in Stroke Magazine
    .

    In this longitudinal case-control study, MRI markers and cognitive performance were assessed in 10 asymptomatic and 6 symptomatic D-CAA mutation carriers and 20 control subjects at baseline and 4 years later.
    assessment
    .
    These MRI markers include hemorrhagic and ischemic manifestations, measures of cerebral blood flow, and vasomotor responsiveness to visual stimuli


    .


    The results showed that in asymptomatic D-CAA mutation carriers, vasomotor reactivity showed a decrease in blood oxygen level-dependent amplitude with time (P=0.
    011) and a prolonged time to peak (P<0.
    001)
    .
    In contrast, no significant changes were found in hemorrhagic markers, ischemic markers, cerebral blood flow, and cognitive performance


    .


    The results showed that in asymptomatic D-CAA mutation carriers, vasomotor reactivity showed a decrease in blood oxygen level-dependent amplitude with time (P=0.


    Amplitude changes in blood oxygen levels since asymptomatic D-caa carriers

    Amplitude changes in blood oxygen levels since asymptomatic D-caa carriers

    Our findings suggest that cerebrovascular reactivity, as measured by blood oxygen level-dependent amplitude and time to peak to visual stimuli, progressively worsens during the asymptomatic phase of D-CAA and can therefore be considered a marker of disease progression


    .


    Our findings suggest that cerebrovascular reactivity, as measured by blood oxygen level-dependent amplitude and time to peak to visual stimuli, progressively worsens during the asymptomatic phase of D-CAA and can therefore be considered a marker of disease progression


    references:

    references:

    Longitudinal Progression of Magnetic Resonance Imaging Markers and Cognition in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.


    Stroke.


    Longitudinal Progression of Magnetic Resonance Imaging Markers and Cognition in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    Stroke.
    2022;0:10.
    1161/STROKEAHA.
    121.
    035826.
    Longitudinal Progression of Magnetic Resonance Imaging Markers and Cognition in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    Stroke.
    2022;0:10.
    1161/STROKEAHA.
    121.
    035826.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.